Journal
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
Volume 17, Issue 4, Pages 418-421Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1529-8027.2012.00442.x
Keywords
Charcot-Marie-Tooth disease; dHMN; exome; glycyl-tRNA synthetase; Korean; mutation
Categories
Funding
- National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea [A111218-GM07]
- National Research Foundation (NRF)
- Ministry of Education, Science, and Technology, Republic of Korea [2011-0013694]
- National Research Foundation of Korea [2011-0013694] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
Glycyl-tRNA synthetase (GARS), which encodes the enzyme responsible for charging tRNA(Gly) with glycine in both the cytoplasm and mitochondria, is implicated to Charcot-Marie-Tooth disease 2D (CMT2D) and distal hereditary motor neuropathy type V (dHMN-V). We performed whole exome sequencing (WES) to identify the genetic defects in the two dHMN families. WES revealed several decades of non-synonymous variants in the CMT and aminoacyl-tRNA synthetase genes. The subsequent capillary sequencing for family members and controls revealed two novel causative mutations, c.598G>A (D200N) and c.794C>T (S265F), in the GARS gene in each dHMN family. Both mutations were cosegregated with affected individuals in each family, and were not found in the 200 controls. The mutation sites were well conserved between the different species and in silico analysis predicted that both mutations may affect protein function. Therefore, we believe that these two novel GARS mutations are the underlying causes of the dHMN phenotype.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available